CAD & Atherosclerosis
From the Journals
Disparities in statin use persist in high-risk Americans
National database analysis finds disparities in primary-prevention statin use persist despite 10-year atherosclerotic cardiovascular disease risk...
Latest News
Even small changes in fitness tied to lower mortality risk
Small changes in cardiorespiratory fitness may have a big impact on health and mortality risk.
News
FDA expands evinacumab approval to younger kids with HoFH
The agency has okayed evinacumab-dgnb for patients aged 5-11 with homozygous familial hypercholesterolemia.
From the Journals
Mediterranean diet linked to 24% reduction in CVD risk in women
The researchers are calling for more sex-specific research to guide clinical practice.
Conference Coverage
Oral PCSK9 inhibitor shows encouraging LDL lowering
A new oral formulation of a PCSK9-inhibiting cholesterol-lowering drug has shown encouraging results in a phase 2 study.
From the Journals
Treat together: Tackle heart disease and obesity simultaneously
A new review outlines how obesity can impair common imaging tests used to diagnose heart disease.
Conference Coverage
Endurance exercise tied to more coronary atherosclerosis
Lifelong endurance athletes had more coronary plaques, including more noncalcified plaques, than fit and healthy individuals, according to a new...
Commentary
Three surprising studies on exercise restriction and an exercise sweet spot
New data ‘do not support universal restriction of vigorous exercise in patients with’ hypertrophic cardiomyopathy.
From the Journals
Causal link found between childhood obesity and adult-onset diabetes
Bigger children have increased risks for almost all subtypes of adult-onset diabetes, a Mendelian randomization study indicates.
Conference Coverage
‘Keto-like’ diet linked to doubling of heart disease risk
But one lipid expert has highlighted limitations of the observational study and advised caution in interpreting the results.
Conference Coverage
In early days, bioabsorbable stent rivals nonabsorbable devices
Late lumen loss with a new bioabsorbable drug-eluting stent is on par with nonabsorbable devices in early data.